GlassScriptPhysician profile
Steven L Jorgensen
NPI 1720445380
$4,065.61
in general payments reported to CMS, 2019-2025
29 companies · $1,323 in 2025
The $1,323 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2020: $97.99 · 2021: $60.35 · 2022: $305 · 2023: $780 · 2024: $1,359 · 2025: $1,323.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,463.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,462.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $895.73 | 2020-2025 | Farxiga, Airsupra, Breztri |
| Otsuka America Pharmaceutical, INC. | $457.92 | 2019-2025 | Rexulti |
| Abbvie INC. | $440.45 | 2021-2025 | |
| Pfizer INC. | $295.37 | 2023-2025 | |
| Glaxosmithkline, LLC. | $259.84 | 2023-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Novo Nordisk INC | $253.31 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $181.38 | 2022-2024 | |
| Amgen INC. | $180.71 | 2023-2025 | Evenity, Repatha, Otezla |
| Merck Sharp & Dohme LLC | $144.09 | 2023-2025 | Verquvo, Vaxneuvance, Capvaxive |
| Phathom Pharmaceuticals, INC. | $112.69 | 2024 | Voquezna |
| Exact Sciences Corporation | $81.88 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Axsome Therapeutics, INC. | $80.66 | 2024-2025 | Auvelity |
| Lilly USA, LLC | $77.13 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Novartis Pharmaceuticals Corporation | $71.98 | 2024-2025 | |
| Sanofi Pasteur INC. | $61.30 | 2023-2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $60.87 | 2025 | Gemtesa |
| Janssen Pharmaceuticals, INC | $59.40 | 2020-2023 | Xarelto |
| Kowa Pharmaceuticals America, INC. | $57.17 | 2021-2023 | Seglentis, Livalo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.74 | 2023-2024 | Jardiance |
| Takeda Pharmaceuticals U.S.A., INC. | $47.71 | 2023-2025 | Trintellix |
| Xeris Pharmaceuticals, INC. | $38.59 | 2025 | Gvoke Hypopen |
| Abbott Laboratories | $36.36 | 2024-2025 | Freestyle Libre 3 |
| Dexcom, INC. | $21.17 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.91 | 2025 | Xifaxan |
| Ascendis Pharma Endocrinology INC | $16.82 | 2025 | Yorvipath |
| Horizon Therapeutics Plc | $16.04 | 2023 | Krystexxa |
| Astellas Pharma US INC | $15.89 | 2023 | Veozah |
| Mylan Specialty L.P. | $15.15 | 2024 | Yupelri |
| Edwards Lifesciences Corporation | $13.35 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Jorgensen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.